Literature DB >> 9862344

A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) and in vitro priming of cytotoxic T lymphocytes.

K Schäkel1, E Mayer, C Federle, M Schmitz, G Riethmüller, E P Rieber.   

Abstract

Originating from a common progenitor cell, dendritic cells (DC) appear to develop along early branched pathways into various yet ill-defined subpopulations residing at various sites throughout the body where they capture and present antigen in the most professional fashion. Here we give evidence for a unique subpopulation of human DC circulating in blood that account for 0.5-1% of blood leukocytes only, their most specific characteristic being the expression of a cell surface protein recognized by a novel monoclonal antibody (M-DC8) which enables their isolation by a one-step immunomagnetic procedure. The isolated cells (> 97% pure) present morphologically as typical dendritic cells. They express the Fc(gamma)RIII (CD16), so far not found on DC, and avidly phagocytose latex beads as well as opsonized erythrocytes. These cells not only present antigens efficiently to naive T cells but also induce purified CD8+ T cells to become alloantigen-specific cytotoxic cells. Furthermore, when loaded with a tyrosinase-derived peptide they stimulate T cells from normal donors and melanoma patients to exhibit MHC-restricted specific cytotoxicity against melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862344     DOI: 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

1.  Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation.

Authors:  L Faulkner; G Buchan; M Baird
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

2.  Quantification of antigen-reactive T cells by a modified ELISPOT assay based on freshly isolated blood dendritic cells.

Authors:  M Schmitz; J Rohayem; R Paul; B Weigle; A Stein; E P Rieber
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

3.  Histamine H(4) receptor activation on human slan-dendritic cells down-regulates their pro-inflammatory capacity.

Authors:  Maria Gschwandtner; Knut Schäkel; Thomas Werfel; Ralf Gutzmer
Journal:  Immunology       Date:  2010-08-16       Impact factor: 7.397

4.  Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.

Authors:  E Mimiola; O Marini; O Perbellini; A Micheletti; W Vermi; S Lonardi; C Costantini; E Meneghelli; A Andreini; C Bonetto; A Vassanelli; M Cantini; E Zoratti; D Massi; A Zamo'; A Leso; G Quaresmini; F Benedetti; G Pizzolo; M A Cassatella; C Tecchio
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

5.  Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells.

Authors:  Rebekka Wehner; Diana Wehrum; Martin Bornhäuser; Senming Zhao; Knut Schäkel; Michael P Bachmann; Uwe Platzbecker; Gerhard Ehninger; E Peter Rieber; Marc Schmitz
Journal:  Haematologica       Date:  2009-06-22       Impact factor: 9.941

Review 6.  [Pathogenesis of psoriasis].

Authors:  K Schäkel; M P Schön; K Ghoreschi
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

7.  Quantitative and functional alterations of 6-sulfo LacNac dendritic cells in multiple myeloma.

Authors:  Baptiste Lamarthée; Frédéric de Vassoigne; Florent Malard; Nicolas Stocker; Inès Boussen; Clémence Médiavilla; Ruoping Tang; Fanny Fava; Laurent Garderet; Zora Marjanovic; Eolia Brissot; Mohamad Mohty; Béatrice Gaugler
Journal:  Oncoimmunology       Date:  2018-03-19       Impact factor: 8.110

8.  Human liver dendritic cells promote T cell hyporesponsiveness.

Authors:  Zubin M Bamboat; Jennifer A Stableford; George Plitas; Bryan M Burt; Hoang M Nguyen; Alexander P Welles; Mithat Gonen; James W Young; Ronald P DeMatteo
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.

Authors:  Marieta Toma; Rebekka Wehner; Anja Kloß; Linda Hübner; Georgia Fodelianaki; Kati Erdmann; Susanne Füssel; Stefan Zastrow; Matthias Meinhardt; Barbara Seliger; Dorothee Brech; Elfriede Noessner; Torsten Tonn; Knut Schäkel; Martin Bornhäuser; Michael P Bachmann; Manfred P Wirth; Gustavo Baretton; Marc Schmitz
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

Review 10.  Modulatory effects of bortezomib on host immune cell functions.

Authors:  Samuel Troy Pellom; Duafalia Fred Dudimah; Menaka Chanu Thounaojam; Thomas Joseph Sayers; Anil Shanker
Journal:  Immunotherapy       Date:  2015-09-01       Impact factor: 4.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.